Tiverton Asset Management’s Bio-Techne TECH Stock Holding History

Tiverton Asset Management’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-5,812	Closed	-$289K	–	728
2019 Q1	$289K	Buy	+5,812	New	+$262K	0.01%	484

Other funds holding TECH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Tiverton Asset Management's TECH Position: Q2 2019 in Review

Tiverton Asset Management sold out of Bio-Techne (TECH) in Q2 2019, closing a stake of 5,812 shares — an estimated $289K sold.

Tiverton Asset Management first reported a position in TECH in Q1 2019 and held it in 1 quarter. The position peaked at $289K in Q1 2019. 369 funds tracked by Wall St. Rank hold TECH as of Q2 2019.

Tiverton Asset Management reported no remaining Bio-Techne position as of Q2 2019 after selling out during the quarter.
Tiverton Asset Management sold 5,812 Bio-Techne shares in Q2 2019, an estimated $289K.
Tiverton Asset Management first reported a position in Bio-Techne in Q1 2019 and held it in 1 quarter.
Tiverton Asset Management's Bio-Techne position peaked at $289K in Q1 2019.
369 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2019.

Based on Tiverton Asset Management's 13F filing for Q2 2019, filed 12 Aug 2019.